![](/img/cover-not-exists.png)
A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis
Goodkin, D. E., Shulman, M., Winkelhake, J., Waubant, E., Andersson, P.-B., Stewart, T., Nelson, S., Fischbein, N., Coyle, P. K., Frohman, E., Jacobs, L., Holcenberg, J., Lee, M., Mocci, S.Volume:
54
Language:
english
Journal:
Neurology
DOI:
10.1212/WNL.54.7.1414
Date:
April, 2000
File:
PDF, 91 KB
english, 2000